APA (7th ed.) Citation

P, L., Z, C., I, G., T, U., D, Ž., D, M., . . . O, C. (2026). Real-world evidence with dapagliflozin in heart failure with reduced ejection fraction in Central Eastern Europe and the Baltic region (EVOLUTION-HF CEE-BA Study). ESC heart failure, 13(3), . https://doi.org/10.1093/eschf/xvag085

Chicago Style (17th ed.) Citation

P, Leszek, et al. "Real-world Evidence with Dapagliflozin in Heart Failure with Reduced Ejection Fraction in Central Eastern Europe and the Baltic Region (EVOLUTION-HF CEE-BA Study)." ESC Heart Failure 13, no. 3 (2026). https://doi.org/10.1093/eschf/xvag085.

MLA (9th ed.) Citation

P, Leszek, et al. "Real-world Evidence with Dapagliflozin in Heart Failure with Reduced Ejection Fraction in Central Eastern Europe and the Baltic Region (EVOLUTION-HF CEE-BA Study)." ESC Heart Failure, vol. 13, no. 3, 2026, https://doi.org/10.1093/eschf/xvag085.